Search
for
Sort by
Research 31–60 of 1000+
- Transmasculine Hormone Therapy
- Endocrine Management of Adult Gender-Dysphoric/Gender-Incongruent Persons: A Clinical Practice Guideline from Endocrine Society of India
- Incidence of alopecia from endocrine therapies in cancer
- [Antiandrogen therapy of acne, falling hair and hirsutism (author's transl)].
- Poor Therapeutic Response in Female Pattern Hair Loss: Mechanisms and a Practical Framework for Clinical Management
- Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone
- Endocrine Aspects of Female Sexual Dysfunction
- Therapeutic Potential of Vitex negundo for the Treatment of Polycystic Ovarian Disease (PCOD): A Review
- 44391 ICI Therapy Toxicities in Psoriasis
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Recommendations of endocrine treatment for patients with gender dysphoria
- Acne: Hormonal concepts and therapy
- Cutaneous manifestations of endocrine-metabolic disease and nutritional deficiency in the elderly
- Exploring obesity-related endocrine disorders beyond diabetes: a narrative review
- Melasma and Endocrine Disorders
- SAT-271 Block and Replace Therapy Successfully Improved Symptoms in Recurrent Cyclic Cushing’s Disease
- Nanoformulated phytochemicals for PCOS: therapeutic potential, translational challenges, and future perspectives
- The eye and the skin in endocrine metabolic diseases
- EP1410 - ECE_1202 - Individualized endocrine care in non-binary individuals: efficacy, safety, and long-term outcomes of microdosing and selective hormone modulators
- Follow‐up of Adverse Drug Reactions from Peginterferon alfa‐2b—Ribavirin Therapy
- Nanotechnology-Driven Antioxidants and Immunomodulators for Polycystic Ovary Syndrome (PCOS) Therapy
- Polycystic Ovary Syndrome: Pathophysiology, Clinical Manifestations and Emerging Therapeutic Approaches
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia
- Oral minoxidil for late alopecia in cancer survivors
- Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Cancer-Related Alopecia: From Etiologies to Global Management
- CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients.